Genome-wide association studies have pointed to other BCAA pathway genes, methylcrotonoylCoA carboxylase 1 (MCCC1) and branched-chain ketoacid dehydrogenase kinase (BCKDK), as being associated with PD22, further implicating BCAA metabolism in PD pathogenesis. Here, BCKDK is linked to Parkinson disease.